CATH Superfamily 3.10.450.60
The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was: waiting to be named.
FunFam 4: Arachidonate 12-lipoxygenase, 12S-type
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 22 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Arachidonate 12-lipoxygenase activity GO:0004052
Catalysis of the reaction: arachidonate + O(2) = (5Z,8Z,10E,12S,14Z)-12-hydroperoxyicosa-5,8,10,14-tetraenoate.
|
10 | P12530 (/IDA) P16050 (/IDA) P16469 (/IDA) P18054 (/IDA) P27479 (/IDA) P39654 (/IDA) P39654 (/IDA) P39655 (/IDA) P39655 (/IDA) Q02759 (/IDA) |
Iron ion binding GO:0005506
Interacting selectively and non-covalently with iron (Fe) ions.
|
8 | P12530 (/ISS) P16050 (/ISS) P27479 (/ISS) P39654 (/ISS) P39654 (/ISS) Q02759 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Phosphatidylinositol-4,5-bisphosphate binding GO:0005546
Interacting selectively and non-covalently with phosphatidylinositol-4,5-bisphosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 4' and 5' positions.
|
8 | P12530 (/ISS) P16469 (/ISS) P27479 (/ISS) P39654 (/ISS) P39654 (/ISS) Q02759 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Arachidonate 12-lipoxygenase activity GO:0004052
Catalysis of the reaction: arachidonate + O(2) = (5Z,8Z,10E,12S,14Z)-12-hydroperoxyicosa-5,8,10,14-tetraenoate.
|
6 | P12530 (/ISS) P39655 (/ISS) P39655 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) Q95103 (/ISS) |
Arachidonate 15-lipoxygenase activity GO:0050473
Catalysis of the reaction: arachidonate + O2 = (5Z,8Z,11Z,13E)-(15S)-15-hydroperoxyicosa-5,8,11,13-tetraenoate.
|
5 | P12530 (/ISS) P16469 (/ISS) P27479 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Arachidonate 12-lipoxygenase activity GO:0004052
Catalysis of the reaction: arachidonate + O(2) = (5Z,8Z,10E,12S,14Z)-12-hydroperoxyicosa-5,8,10,14-tetraenoate.
|
4 | P39654 (/ISO) P39654 (/ISO) P39655 (/ISO) P39655 (/ISO) |
Hepoxilin-epoxide hydrolase activity GO:0047977
Catalysis of the reaction: (5Z,9E,14Z)-(8x,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoate + H2O = (5Z,9E,14Z)-(8x,11x,12S)-8,11,12-trihydroxyicosa-5,9,14-trienoate.
|
4 | P18054 (/ISS) P39655 (/ISS) P39655 (/ISS) Q95103 (/ISS) |
Arachidonate 15-lipoxygenase activity GO:0050473
Catalysis of the reaction: arachidonate + O2 = (5Z,8Z,11Z,13E)-(15S)-15-hydroperoxyicosa-5,8,11,13-tetraenoate.
|
4 | P16050 (/IDA) P39654 (/IDA) P39654 (/IDA) Q02759 (/IDA) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
2 | P16050 (/IPI) P18054 (/IPI) |
Phosphatidylinositol-4,5-bisphosphate binding GO:0005546
Interacting selectively and non-covalently with phosphatidylinositol-4,5-bisphosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 4' and 5' positions.
|
2 | P39654 (/ISO) P39654 (/ISO) |
Linoleate 13S-lipoxygenase activity GO:0016165
Catalysis of the reaction: linoleate + O2 = (9Z,11E)-(13S)-13-hydroperoxyoctadeca-9,11-dienoate.
|
2 | P39655 (/ISO) P39655 (/ISO) |
Hepoxilin-epoxide hydrolase activity GO:0047977
Catalysis of the reaction: (5Z,9E,14Z)-(8x,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoate + H2O = (5Z,9E,14Z)-(8x,11x,12S)-8,11,12-trihydroxyicosa-5,9,14-trienoate.
|
2 | P39654 (/ISO) P39654 (/ISO) |
Arachidonate 15-lipoxygenase activity GO:0050473
Catalysis of the reaction: arachidonate + O2 = (5Z,8Z,11Z,13E)-(15S)-15-hydroperoxyicosa-5,8,11,13-tetraenoate.
|
2 | P39654 (/ISO) P39654 (/ISO) |
Hepoxilin A3 synthase activity GO:0051120
Catalysis of the reaction: 12S-5Z,8Z,10E,14Z-12-hydro(pero)xy-eicosa-5,8,10,14-tetraenoic acid = (5Z,9E,14Z)-(8,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoate. 12S-5Z,8Z,10E,14Z-12-hydro(pero)xy-eicosa-5,8,10,14-tetraenoic acid is also known as 12S-HpETE, and (5Z,9E,14Z)-(8,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoate as hepoxilin A3.
|
2 | P39654 (/ISO) P39654 (/ISO) |
Iron ion binding GO:0005506
Interacting selectively and non-covalently with iron (Fe) ions.
|
1 | P16469 (/IDA) |
Phosphatidylinositol-4,5-bisphosphate binding GO:0005546
Interacting selectively and non-covalently with phosphatidylinositol-4,5-bisphosphate, a derivative of phosphatidylinositol in which the inositol ring is phosphorylated at the 4' and 5' positions.
|
1 | P16050 (/IDA) |
Linoleate 13S-lipoxygenase activity GO:0016165
Catalysis of the reaction: linoleate + O2 = (9Z,11E)-(13S)-13-hydroperoxyoctadeca-9,11-dienoate.
|
1 | P18054 (/IDA) |
Potassium channel inhibitor activity GO:0019870
Stops, prevents, or reduces the activity of a potassium channel.
|
1 | Q02759 (/TAS) |
Hepoxilin-epoxide hydrolase activity GO:0047977
Catalysis of the reaction: (5Z,9E,14Z)-(8x,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoate + H2O = (5Z,9E,14Z)-(8x,11x,12S)-8,11,12-trihydroxyicosa-5,9,14-trienoate.
|
1 | Q02759 (/IDA) |
Arachidonate 15-lipoxygenase activity GO:0050473
Catalysis of the reaction: arachidonate + O2 = (5Z,8Z,11Z,13E)-(15S)-15-hydroperoxyicosa-5,8,11,13-tetraenoate.
|
1 | P16050 (/NAS) |
Arachidonate 15-lipoxygenase activity GO:0050473
Catalysis of the reaction: arachidonate + O2 = (5Z,8Z,11Z,13E)-(15S)-15-hydroperoxyicosa-5,8,11,13-tetraenoate.
|
1 | P16050 (/TAS) |
Hepoxilin A3 synthase activity GO:0051120
Catalysis of the reaction: 12S-5Z,8Z,10E,14Z-12-hydro(pero)xy-eicosa-5,8,10,14-tetraenoic acid = (5Z,9E,14Z)-(8,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoate. 12S-5Z,8Z,10E,14Z-12-hydro(pero)xy-eicosa-5,8,10,14-tetraenoic acid is also known as 12S-HpETE, and (5Z,9E,14Z)-(8,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoate as hepoxilin A3.
|
1 | Q02759 (/IDA) |
There are 101 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Arachidonic acid metabolic process GO:0019369
The chemical reactions and pathways involving arachidonic acid, a straight chain fatty acid with 20 carbon atoms and four double bonds per molecule. Arachidonic acid is the all-Z-(5,8,11,14)-isomer.
|
12 |
D3ZQF9 (/IDA)
F1LQ70 (/IDA)
P12530 (/IDA)
P16050 (/IDA)
P16469 (/IDA)
P18054 (/IDA)
P27479 (/IDA)
P39654 (/IDA)
P39654 (/IDA)
P39655 (/IDA)
(2 more) |
Lipoxygenase pathway GO:0019372
The chemical reactions and pathways by which an unsaturated fatty acid (such as arachidonic acid or linolenic acid) is converted to other compounds, and in which the first step is hydroperoxide formation catalyzed by lipoxygenase.
|
12 |
D3ZQF9 (/IDA)
F1LQ70 (/IDA)
P12530 (/IDA)
P16050 (/IDA)
P16469 (/IDA)
P18054 (/IDA)
P27479 (/IDA)
P39654 (/IDA)
P39654 (/IDA)
P39655 (/IDA)
(2 more) |
Lipoxin A4 biosynthetic process GO:2001303
The chemical reactions and pathways resulting in the formation of lipoxin A4. Lipoxin A4 is a C20 hydroxy fatty acid having (5S)-, (6R)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds.
|
10 | F1LQ70 (/ISS) P12530 (/ISS) P16050 (/ISS) P16469 (/ISS) P27479 (/ISS) P39655 (/ISS) P39655 (/ISS) Q02759 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Hepoxilin biosynthetic process GO:0051122
The chemical reactions and pathways resulting in the formation of hepoxilins, a class of bioactive icosanoids with roles in the regulation of cell physiology.
|
9 | P12530 (/ISS) P16050 (/ISS) P18054 (/ISS) P39654 (/ISS) P39654 (/ISS) P39655 (/ISS) P39655 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Positive regulation of cell-substrate adhesion GO:0010811
Any process that increases the frequency, rate or extent of cell-substrate adhesion. Cell-substrate adhesion is the attachment of a cell to the underlying substrate via adhesion molecules.
|
8 | P12530 (/ISS) P16469 (/ISS) P27479 (/ISS) P39654 (/ISS) P39654 (/ISS) Q02759 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Cellular response to interleukin-13 GO:0035963
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-13 stimulus.
|
8 | P12530 (/ISS) P16469 (/ISS) P27479 (/ISS) P39654 (/ISS) P39654 (/ISS) Q02759 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
8 | P12530 (/ISS) P16469 (/ISS) P27479 (/ISS) P39654 (/ISS) P39654 (/ISS) Q02759 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Cellular response to calcium ion GO:0071277
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus.
|
8 | P12530 (/ISS) P16469 (/ISS) P27479 (/ISS) P39654 (/ISS) P39654 (/ISS) Q02759 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Ossification GO:0001503
The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone or a bony substance.
|
7 | P12530 (/ISS) P16050 (/ISS) P16469 (/ISS) P27479 (/ISS) Q02759 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Negative regulation of adaptive immune response GO:0002820
Any process that stops, prevents, or reduces the frequency, rate, or extent of an adaptive immune response.
|
7 | P12530 (/ISS) P16050 (/ISS) P16469 (/ISS) P27479 (/ISS) Q02759 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Phosphatidylethanolamine biosynthetic process GO:0006646
The chemical reactions and pathways resulting in the formation of phosphatidylethanolamine, any of a class of glycerophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of ethanolamine.
|
7 | P12530 (/ISS) P16050 (/ISS) P16469 (/ISS) P27479 (/ISS) Q02759 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Bone mineralization GO:0030282
The deposition of hydroxyapatite, a form of calcium phosphate with the formula Ca10(PO4)6(OH)2, in bone tissue.
|
7 | P12530 (/ISS) P16050 (/ISS) P16469 (/ISS) P27479 (/ISS) Q02759 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Positive regulation of actin filament polymerization GO:0030838
Any process that activates or increases the frequency, rate or extent of actin polymerization.
|
7 | P12530 (/ISS) P16050 (/ISS) P16469 (/ISS) P27479 (/ISS) Q02759 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Response to endoplasmic reticulum stress GO:0034976
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stress acting at the endoplasmic reticulum. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen.
|
7 | P12530 (/ISS) P16050 (/ISS) P16469 (/ISS) P27479 (/ISS) Q02759 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Regulation of peroxisome proliferator activated receptor signaling pathway GO:0035358
Any process that modulates the frequency, rate or extent of the peroxisome proliferator activated receptor signaling pathway.
|
7 | P12530 (/ISS) P16050 (/ISS) P16469 (/ISS) P27479 (/ISS) Q02759 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Wound healing GO:0042060
The series of events that restore integrity to a damaged tissue, following an injury.
|
7 | P12530 (/ISS) P16050 (/ISS) P16469 (/ISS) P27479 (/ISS) Q02759 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Apoptotic cell clearance GO:0043277
The recognition and removal of an apoptotic cell by a neighboring cell or by a phagocyte.
|
7 | P12530 (/ISS) P16050 (/ISS) P16469 (/ISS) P27479 (/ISS) Q02759 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Regulation of engulfment of apoptotic cell GO:1901074
Any process that modulates the frequency, rate or extent of engulfment of apoptotic cell.
|
7 | P12530 (/ISS) P16050 (/ISS) P16469 (/ISS) P27479 (/ISS) Q02759 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Arachidonic acid metabolic process GO:0019369
The chemical reactions and pathways involving arachidonic acid, a straight chain fatty acid with 20 carbon atoms and four double bonds per molecule. Arachidonic acid is the all-Z-(5,8,11,14)-isomer.
|
6 | P39654 (/IMP) P39654 (/IMP) P39655 (/IMP) P39655 (/IMP) P55249 (/IMP) P55249 (/IMP) |
Arachidonic acid metabolic process GO:0019369
The chemical reactions and pathways involving arachidonic acid, a straight chain fatty acid with 20 carbon atoms and four double bonds per molecule. Arachidonic acid is the all-Z-(5,8,11,14)-isomer.
|
6 | P39654 (/ISO) P39654 (/ISO) P39655 (/ISO) P39655 (/ISO) P55249 (/ISO) P55249 (/ISO) |
Lipoxygenase pathway GO:0019372
The chemical reactions and pathways by which an unsaturated fatty acid (such as arachidonic acid or linolenic acid) is converted to other compounds, and in which the first step is hydroperoxide formation catalyzed by lipoxygenase.
|
6 | P39654 (/IMP) P39654 (/IMP) P39655 (/IMP) P39655 (/IMP) P55249 (/IMP) P55249 (/IMP) |
Lipoxygenase pathway GO:0019372
The chemical reactions and pathways by which an unsaturated fatty acid (such as arachidonic acid or linolenic acid) is converted to other compounds, and in which the first step is hydroperoxide formation catalyzed by lipoxygenase.
|
6 | P39654 (/ISO) P39654 (/ISO) P39655 (/ISO) P39655 (/ISO) P55249 (/ISO) P55249 (/ISO) |
Arachidonic acid metabolic process GO:0019369
The chemical reactions and pathways involving arachidonic acid, a straight chain fatty acid with 20 carbon atoms and four double bonds per molecule. Arachidonic acid is the all-Z-(5,8,11,14)-isomer.
|
4 | P12530 (/ISS) P18054 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Hepoxilin biosynthetic process GO:0051122
The chemical reactions and pathways resulting in the formation of hepoxilins, a class of bioactive icosanoids with roles in the regulation of cell physiology.
|
4 | P39654 (/ISO) P39654 (/ISO) P39655 (/ISO) P39655 (/ISO) |
Negative regulation of muscle cell apoptotic process GO:0010656
Any process that decreases the rate or frequency of muscle cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a muscle cell and result in its death.
|
3 | F1LQ70 (/ISS) P39655 (/ISS) P39655 (/ISS) |
Lipoxygenase pathway GO:0019372
The chemical reactions and pathways by which an unsaturated fatty acid (such as arachidonic acid or linolenic acid) is converted to other compounds, and in which the first step is hydroperoxide formation catalyzed by lipoxygenase.
|
3 | P12530 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Fatty acid oxidation GO:0019395
The removal of one or more electrons from a fatty acid, with or without the concomitant removal of a proton or protons, by reaction with an electron-accepting substance, by addition of oxygen or by removal of hydrogen.
|
3 | P39655 (/ISS) P39655 (/ISS) Q02759 (/ISS) |
Linoleic acid metabolic process GO:0043651
The chemical reactions and pathways involving linoleic acid, an unsaturated omega-6 fatty acid that has the molecular formula C18H32O2.
|
3 | P12530 (/IDA) P16469 (/IDA) P18054 (/IDA) |
Linoleic acid metabolic process GO:0043651
The chemical reactions and pathways involving linoleic acid, an unsaturated omega-6 fatty acid that has the molecular formula C18H32O2.
|
3 | F1LQ70 (/ISS) P39655 (/ISS) P39655 (/ISS) |
Leukotriene A4 metabolic process GO:1901751
The chemical reactions and pathways involving leukotriene A4.
|
3 | F1LQ70 (/ISS) P39655 (/ISS) P39655 (/ISS) |
Lipoxin B4 biosynthetic process GO:2001306
The chemical reactions and pathways resulting in the formation of lipoxin B4. Lipoxin B4 is a C20 hydroxy fatty acid having (5S)-, (14R)- and (15S)-hydroxy groups as well as (6E)- (8Z)-, (10E)- and (12E)-double bonds.
|
3 | F1LQ70 (/ISS) P39655 (/ISS) P39655 (/ISS) |
Ossification GO:0001503
The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone or a bony substance.
|
2 | P39654 (/IMP) P39654 (/IMP) |
Negative regulation of adaptive immune response GO:0002820
Any process that stops, prevents, or reduces the frequency, rate, or extent of an adaptive immune response.
|
2 | P39654 (/IMP) P39654 (/IMP) |
Phosphatidylethanolamine biosynthetic process GO:0006646
The chemical reactions and pathways resulting in the formation of phosphatidylethanolamine, any of a class of glycerophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of ethanolamine.
|
2 | P39654 (/IMP) P39654 (/IMP) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P39655 (/ISO) P39655 (/ISO) |
Negative regulation of muscle cell apoptotic process GO:0010656
Any process that decreases the rate or frequency of muscle cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a muscle cell and result in its death.
|
2 | P39655 (/ISO) P39655 (/ISO) |
Positive regulation of cell-substrate adhesion GO:0010811
Any process that increases the frequency, rate or extent of cell-substrate adhesion. Cell-substrate adhesion is the attachment of a cell to the underlying substrate via adhesion molecules.
|
2 | P39654 (/ISO) P39654 (/ISO) |
Positive regulation of cell death GO:0010942
Any process that increases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
2 | P39655 (/ISO) P39655 (/ISO) |
Arachidonic acid metabolic process GO:0019369
The chemical reactions and pathways involving arachidonic acid, a straight chain fatty acid with 20 carbon atoms and four double bonds per molecule. Arachidonic acid is the all-Z-(5,8,11,14)-isomer.
|
2 | P16050 (/NAS) Q02759 (/NAS) |
Lipoxygenase pathway GO:0019372
The chemical reactions and pathways by which an unsaturated fatty acid (such as arachidonic acid or linolenic acid) is converted to other compounds, and in which the first step is hydroperoxide formation catalyzed by lipoxygenase.
|
2 | P16050 (/TAS) P18054 (/TAS) |
Fatty acid oxidation GO:0019395
The removal of one or more electrons from a fatty acid, with or without the concomitant removal of a proton or protons, by reaction with an electron-accepting substance, by addition of oxygen or by removal of hydrogen.
|
2 | P39655 (/ISO) P39655 (/ISO) |
Bone mineralization GO:0030282
The deposition of hydroxyapatite, a form of calcium phosphate with the formula Ca10(PO4)6(OH)2, in bone tissue.
|
2 | P39654 (/IMP) P39654 (/IMP) |
Positive regulation of actin filament polymerization GO:0030838
Any process that activates or increases the frequency, rate or extent of actin polymerization.
|
2 | P39654 (/IMP) P39654 (/IMP) |
Positive regulation of heterotypic cell-cell adhesion GO:0034116
Any process that activates or increases the frequency, rate, or extent of heterotypic cell-cell adhesion.
|
2 | P39654 (/ISO) P39654 (/ISO) |
Response to endoplasmic reticulum stress GO:0034976
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stress acting at the endoplasmic reticulum. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen.
|
2 | P39654 (/IMP) P39654 (/IMP) |
Regulation of peroxisome proliferator activated receptor signaling pathway GO:0035358
Any process that modulates the frequency, rate or extent of the peroxisome proliferator activated receptor signaling pathway.
|
2 | P39654 (/IMP) P39654 (/IMP) |
Cellular response to interleukin-13 GO:0035963
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-13 stimulus.
|
2 | P39654 (/ISO) P39654 (/ISO) |
Wound healing GO:0042060
The series of events that restore integrity to a damaged tissue, following an injury.
|
2 | P39654 (/IMP) P39654 (/IMP) |
Long-chain fatty acid biosynthetic process GO:0042759
The chemical reactions and pathways resulting in the formation of long-chain fatty acids, any fatty acid with a chain length between C13 and C22.
|
2 | P16050 (/TAS) P18054 (/TAS) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
2 | P39655 (/ISO) P39655 (/ISO) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
2 | P39655 (/ISS) P39655 (/ISS) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
2 | P39655 (/ISO) P39655 (/ISO) |
Apoptotic cell clearance GO:0043277
The recognition and removal of an apoptotic cell by a neighboring cell or by a phagocyte.
|
2 | P39654 (/IMP) P39654 (/IMP) |
Positive regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043280
Any process that activates or increases the activity of a cysteine-type endopeptidase involved in the apoptotic process.
|
2 | P39655 (/ISO) P39655 (/ISO) |
Positive regulation of blood vessel endothelial cell migration GO:0043536
Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
|
2 | P39655 (/ISO) P39655 (/ISO) |
Positive regulation of smooth muscle cell proliferation GO:0048661
Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
|
2 | P39655 (/ISO) P39655 (/ISO) |
Hepoxilin biosynthetic process GO:0051122
The chemical reactions and pathways resulting in the formation of hepoxilins, a class of bioactive icosanoids with roles in the regulation of cell physiology.
|
2 | F1LQ70 (/IDA) Q02759 (/IDA) |
Positive regulation of mitochondrial depolarization GO:0051901
Any process that activates, maintains or increases the frequency, rate or extent of the change in the membrane potential of the mitochondria from negative to positive.
|
2 | P39655 (/ISO) P39655 (/ISO) |
Establishment of skin barrier GO:0061436
Establishment of the epithelial barrier, the functional barrier in the skin that limits its permeability.
|
2 | P39655 (/IMP) P39655 (/IMP) |
Establishment of skin barrier GO:0061436
Establishment of the epithelial barrier, the functional barrier in the skin that limits its permeability.
|
2 | F1LQ70 (/ISS) P18054 (/ISS) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
2 | P39654 (/ISO) P39654 (/ISO) |
Cellular response to calcium ion GO:0071277
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus.
|
2 | P39654 (/ISO) P39654 (/ISO) |
Negative regulation of platelet aggregation GO:0090331
Any process that decreases the rate, frequency or extent of platelet aggregation. Platelet aggregation is the adhesion of one platelet to one or more other platelets via adhesion molecules.
|
2 | P39655 (/IMP) P39655 (/IMP) |
Negative regulation of platelet aggregation GO:0090331
Any process that decreases the rate, frequency or extent of platelet aggregation. Platelet aggregation is the adhesion of one platelet to one or more other platelets via adhesion molecules.
|
2 | F1LQ70 (/ISS) P18054 (/ISS) |
Positive regulation of blood vessel diameter GO:0097755
Any process that increases the diameter of blood vessels.
|
2 | P39655 (/ISO) P39655 (/ISO) |
Regulation of engulfment of apoptotic cell GO:1901074
Any process that modulates the frequency, rate or extent of engulfment of apoptotic cell.
|
2 | P39654 (/IMP) P39654 (/IMP) |
Positive regulation of endothelial tube morphogenesis GO:1905956
Any process that activates or increases the frequency, rate or extent of endothelial tube morphogenesis.
|
2 | P39655 (/ISO) P39655 (/ISO) |
Lipoxin A4 biosynthetic process GO:2001303
The chemical reactions and pathways resulting in the formation of lipoxin A4. Lipoxin A4 is a C20 hydroxy fatty acid having (5S)-, (6R)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds.
|
2 | P39654 (/IMP) P39654 (/IMP) |
Lipoxin A4 biosynthetic process GO:2001303
The chemical reactions and pathways resulting in the formation of lipoxin A4. Lipoxin A4 is a C20 hydroxy fatty acid having (5S)-, (6R)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds.
|
2 | P39655 (/ISO) P39655 (/ISO) |
Lipoxin B4 biosynthetic process GO:2001306
The chemical reactions and pathways resulting in the formation of lipoxin B4. Lipoxin B4 is a C20 hydroxy fatty acid having (5S)-, (14R)- and (15S)-hydroxy groups as well as (6E)- (8Z)-, (10E)- and (12E)-double bonds.
|
2 | P39655 (/ISO) P39655 (/ISO) |
Leukotriene metabolic process GO:0006691
The chemical reactions and pathways involving leukotriene, a pharmacologically active substance derived from a polyunsaturated fatty acid, such as arachidonic acid.
|
1 | P16050 (/TAS) |
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
|
1 | P16050 (/TAS) |
Aging GO:0007568
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
|
1 | F1LQ70 (/IEP) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
1 | F1LQ70 (/IMP) |
Negative regulation of muscle cell apoptotic process GO:0010656
Any process that decreases the rate or frequency of muscle cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a muscle cell and result in its death.
|
1 | P18054 (/IMP) |
Positive regulation of cell-substrate adhesion GO:0010811
Any process that increases the frequency, rate or extent of cell-substrate adhesion. Cell-substrate adhesion is the attachment of a cell to the underlying substrate via adhesion molecules.
|
1 | P16050 (/IDA) |
Positive regulation of cell death GO:0010942
Any process that increases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
1 | F1LQ70 (/IMP) |
Cytokine-mediated signaling pathway GO:0019221
A series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | P16050 (/TAS) |
Fatty acid oxidation GO:0019395
The removal of one or more electrons from a fatty acid, with or without the concomitant removal of a proton or protons, by reaction with an electron-accepting substance, by addition of oxygen or by removal of hydrogen.
|
1 | P18054 (/IMP) |
Positive regulation of heterotypic cell-cell adhesion GO:0034116
Any process that activates or increases the frequency, rate, or extent of heterotypic cell-cell adhesion.
|
1 | Q02759 (/IMP) |
Cellular response to interleukin-13 GO:0035963
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-13 stimulus.
|
1 | P16050 (/IMP) |
Regulation of membrane potential GO:0042391
Any process that modulates the establishment or extent of a membrane potential, the electric potential existing across any membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
|
1 | Q02759 (/TAS) |
Superoxide anion generation GO:0042554
The enzymatic generation of superoxide, the superoxide anion O2- (superoxide free radical), or any compound containing this species, by a cell in response to environmental stress, thereby mediating the activation of various stress-inducible signaling pathways.
|
1 | P18054 (/NAS) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
1 | F1LQ70 (/IMP) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
1 | F1LQ70 (/IMP) |
Positive regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043280
Any process that activates or increases the activity of a cysteine-type endopeptidase involved in the apoptotic process.
|
1 | F1LQ70 (/IMP) |
Positive regulation of blood vessel endothelial cell migration GO:0043536
Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
|
1 | F1LQ70 (/IMP) |
Negative regulation of cell volume GO:0045794
Any process that decreases cell volume.
|
1 | Q02759 (/TAS) |
Icosanoid biosynthetic process GO:0046456
The chemical reactions and pathways resulting in the formation of icosanoids, any of a group of C20 polyunsaturated fatty acids.
|
1 | Q02759 (/NAS) |
Positive regulation of smooth muscle cell proliferation GO:0048661
Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
|
1 | F1LQ70 (/IMP) |
Hepoxilin metabolic process GO:0051121
The chemical reactions and pathways involving hepoxilins, a class of bioactive icosanoids with roles in the regulation of cell physiology.
|
1 | P18054 (/TAS) |
Positive regulation of mitochondrial depolarization GO:0051901
Any process that activates, maintains or increases the frequency, rate or extent of the change in the membrane potential of the mitochondria from negative to positive.
|
1 | F1LQ70 (/IMP) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
1 | P16050 (/IMP) |
Cellular response to calcium ion GO:0071277
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus.
|
1 | P16050 (/IDA) |
Cellular response to lipid GO:0071396
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipid stimulus.
|
1 | F1LQ70 (/IEP) |
Positive regulation of blood vessel diameter GO:0097755
Any process that increases the diameter of blood vessels.
|
1 | F1LQ70 (/IMP) |
Leukotriene A4 metabolic process GO:1901751
The chemical reactions and pathways involving leukotriene A4.
|
1 | P18054 (/IDA) |
Positive regulation of endothelial tube morphogenesis GO:1905956
Any process that activates or increases the frequency, rate or extent of endothelial tube morphogenesis.
|
1 | F1LQ70 (/IMP) |
Lipoxin biosynthetic process GO:2001301
The chemical reactions and pathways resulting in the formation of a lipoxin. A lipoxin is a non-classic eicosanoid and signalling molecule that has four conjugated double bonds and is derived from arachidonic acid.
|
1 | P18054 (/TAS) |
Lipoxin A4 biosynthetic process GO:2001303
The chemical reactions and pathways resulting in the formation of lipoxin A4. Lipoxin A4 is a C20 hydroxy fatty acid having (5S)-, (6R)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds.
|
1 | P18054 (/IDA) |
Lipoxin B4 biosynthetic process GO:2001306
The chemical reactions and pathways resulting in the formation of lipoxin B4. Lipoxin B4 is a C20 hydroxy fatty acid having (5S)-, (14R)- and (15S)-hydroxy groups as well as (6E)- (8Z)-, (10E)- and (12E)-double bonds.
|
1 | P18054 (/IDA) |
There are 22 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
11 |
F1LQ70 (/ISS)
P12530 (/ISS)
P16469 (/ISS)
P27479 (/ISS)
P39654 (/ISS)
P39654 (/ISS)
P39655 (/ISS)
P39655 (/ISS)
Q02759 (/ISS)
Q5RBE8 (/ISS)
(1 more) |
Lipid droplet GO:0005811
An intracellular non-membrane-bounded organelle comprising a matrix of coalesced lipids surrounded by a phospholipid monolayer. May include associated proteins.
|
8 | P12530 (/ISS) P16469 (/ISS) P27479 (/ISS) P39654 (/ISS) P39654 (/ISS) Q02759 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Extrinsic component of cytoplasmic side of plasma membrane GO:0031234
The component of a plasma membrane consisting of gene products and protein complexes that are loosely bound to its cytoplasmic surface, but not integrated into the hydrophobic region.
|
8 | P12530 (/ISS) P16469 (/ISS) P27479 (/ISS) P39654 (/ISS) P39654 (/ISS) Q02759 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
7 | P12530 (/ISS) P16050 (/ISS) P16469 (/ISS) P27479 (/ISS) Q02759 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
6 | F1LQ70 (/IDA) P18054 (/IDA) P39654 (/IDA) P39654 (/IDA) P39655 (/IDA) P39655 (/IDA) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
6 | F1LQ70 (/IDA) P16050 (/IDA) P18054 (/IDA) P39654 (/IDA) P39654 (/IDA) Q02759 (/IDA) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
6 | P12530 (/ISS) P16050 (/ISS) P16469 (/ISS) P27479 (/ISS) Q5RBE8 (/ISS) Q5RBE8 (/ISS) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
4 | P39654 (/ISO) P39654 (/ISO) P39655 (/ISO) P39655 (/ISO) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
4 | P39654 (/ISO) P39654 (/ISO) P39655 (/ISO) P39655 (/ISO) |
Sarcolemma GO:0042383
The outer membrane of a muscle cell, consisting of the plasma membrane, a covering basement membrane (about 100 nm thick and sometimes common to more than one fiber), and the associated loose network of collagen fibers.
|
4 | F1LQ70 (/ISS) P39655 (/ISS) P39655 (/ISS) Q02759 (/ISS) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
2 | P39655 (/ISO) P39655 (/ISO) |
Lipid droplet GO:0005811
An intracellular non-membrane-bounded organelle comprising a matrix of coalesced lipids surrounded by a phospholipid monolayer. May include associated proteins.
|
2 | P39654 (/ISO) P39654 (/ISO) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
2 | P16050 (/TAS) P18054 (/TAS) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
2 | P39654 (/IDA) P39654 (/IDA) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
2 | P16050 (/IDA) P18054 (/IDA) |
Extrinsic component of cytoplasmic side of plasma membrane GO:0031234
The component of a plasma membrane consisting of gene products and protein complexes that are loosely bound to its cytoplasmic surface, but not integrated into the hydrophobic region.
|
2 | P39654 (/ISO) P39654 (/ISO) |
Sarcolemma GO:0042383
The outer membrane of a muscle cell, consisting of the plasma membrane, a covering basement membrane (about 100 nm thick and sometimes common to more than one fiber), and the associated loose network of collagen fibers.
|
2 | F1LQ70 (/IDA) P18054 (/IDA) |
Sarcolemma GO:0042383
The outer membrane of a muscle cell, consisting of the plasma membrane, a covering basement membrane (about 100 nm thick and sometimes common to more than one fiber), and the associated loose network of collagen fibers.
|
2 | P39655 (/ISO) P39655 (/ISO) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
1 | F1LQ70 (/ISS) |
Lipid droplet GO:0005811
An intracellular non-membrane-bounded organelle comprising a matrix of coalesced lipids surrounded by a phospholipid monolayer. May include associated proteins.
|
1 | P16050 (/IDA) |
Extrinsic component of cytoplasmic side of plasma membrane GO:0031234
The component of a plasma membrane consisting of gene products and protein complexes that are loosely bound to its cytoplasmic surface, but not integrated into the hydrophobic region.
|
1 | P16050 (/IDA) |
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
|
1 | P18054 (/HDA) |